8.77
Prothena Corporation Plc Aktie (PRTA) Neueste Nachrichten
Prothena Corporation plc stock outlook for YEARPortfolio Profit Report & High Win Rate Trade Alerts - Newser
Strategies to average down on Prothena Corporation plcJuly 2025 Update & Short-Term High Return Ideas - Newser
Is Prothena Corporation plc still worth holding after the dipWeekly Trend Report & Intraday High Probability Setup Alerts - Newser
How institutional ownership impacts Prothena Corporation plc stockWeekly Risk Summary & Real-Time Chart Pattern Alerts - Newser
Can swing trading help recover from Prothena Corporation plc lossesWeekly Stock Recap & Consistent Growth Equity Picks - Newser
Tick level data insight on Prothena Corporation plc volatilityBuy Signal & Free Weekly Chart Analysis and Trade Guides - Newser
Using data models to predict Prothena Corporation plc stock movement2025 Volume Leaders & AI Driven Stock Movement Reports - Newser
Earnings visualization tools for Prothena Corporation plcQuarterly Market Review & Real-Time Stock Price Movement Reports - Newser
Is Prothena Corporation plc trending in predictive chart modelsMarket Risk Analysis & Short-Term High Return Ideas - Newser
Relative strength of Prothena Corporation plc in sector analysisJuly 2025 Catalysts & Safe Capital Investment Plans - Newser
Ranking Prothena Corporation plc among high performing stocks via tools2025 Technical Overview & Stock Portfolio Risk Management - Newser
Will a bounce in Prothena Corporation plc offer an exitPortfolio Update Summary & Target Return Focused Stock Picks - Newser
Key resistance and support levels for Prothena Corporation plcPrice Action & Expert Curated Trade Ideas - Newser
Will Prothena Corporation plc see short term momentum2025 Trading Recap & Growth Focused Entry Reports - Newser
Recovery Signals Appearing in Prothena Corporation plc Charts2025 Macro Impact & High Conviction Buy Zone Picks - beatles.ru
Is Prothena Corporation plc Forming a Consolidation Base2025 Historical Comparison & Accurate Buy Signal Alerts - beatles.ru
Prothena Corporation plc Stocks Attracting Dip Buyers2025 Support & Resistance & Accurate Intraday Trade Tips - newsyoung.net
Published on: 2025-08-14 23:29:29 - sundaytimes.kr
Prothena’s SWOT analysis: stock outlook shifts amid pipeline changes By Investing.com - Investing.com Canada
Prothena’s SWOT analysis: stock outlook shifts amid pipeline changes - Investing.com
Can trapped investors hope for a rebound in Prothena Corporation plcFree Investment Strategy With Low Risk - Newser
What MACD signals say about Prothena Corporation plcForecast Model for Intraday Buy Signals - Newser
How to escape a deep drawdown in Prothena Corporation plcFree Low Risk High Return Opportunities - Newser
How to build a dashboard for Prothena Corporation plc stockSummary of Reliable Long-Term Trade Models - Newser
Building trade automation scripts for Prothena Corporation plcBreakout Stock Opportunities with Low Drawdown - Newser
Volume spikes in Prothena Corporation plc stock – what they meanFree Safe Entry Stock Watch Suggestions - Newser
How Prothena Corporation plc stock performs during market volatilityLow Exposure Strategy with Sector Analysis - Newser
Trend Reversal Possible in Prothena Corporation plc Charts IndicateSmart Allocation Stock Pick Insights Gaining Interest - metal.it
Royal Bank Of Canada Cuts Prothena (NASDAQ:PRTA) Price Target to $10.00 - Defense World
Prothena Announces that Novo Nordisk Will Advance Coramitug (Formerly PRX004) into Phase 3 Development for ATTR Amyloidosis with Cardiomyopathy - BioSpace
Novo Nordisk Commits To Advancing Prothena Corp-Developed Drug Into Late Stage Trial: Retail Turns Hopeful - Investing.com India
Prothena (PRTA) Surges on Novo Nordisk's Phase 3 Plans for ATTR Amyloidosis Drug - GuruFocus
Prothena’s Coramitug Advances to Phase 3 with Novo Nordisk - TipRanks
Prothena Announces that Novo Nordisk Will Advance Coramitug (For - GuruFocus
Breakthrough: Novo Nordisk Takes Prothena's ATTR Drug to Final Trial Stage with $1.2B Milestone Potential - Stock Titan
Applying sector rotation models to Prothena Corporation plcFree Swing Trading Entry Point Signals - Newser
Prothena announces that Novo Nordisk will advance Coramitug into phase 3 development - MarketScreener
Prothena stock price target lowered to $10 at RBC on program discontinuation By Investing.com - Investing.com South Africa
Prothena stock price target lowered to $10 at RBC on program discontinuation - Investing.com Nigeria
PRTA: RBC Capital Maintains Rating, Lowers Price Target | PRTA S - GuruFocus
9 Analysts Assess Prothena Corp: What You Need To Know - 富途牛牛
Prothena’s Losses Grow As Revenue Drops And Programs Wind Down - Finimize
RBC Cuts Price Target on Prothena to $10 From $18, Keeps Sector Perform, Speculative Risk - MarketScreener
Prothena Corp (PRTA) Maintains 'Buy' Rating with $18 Target by C - GuruFocus
JMP reiterates Market Outperform rating on Prothena stock ahead of key data - Investing.com Nigeria
Prothena Reports Second Quarter 2025 Financial Results and Business Highlights - BioSpace
Prothena Reports Q2 2025 Financial Results and Pipeline Progress - TipRanks
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):